127 related articles for article (PubMed ID: 34929229)
21. Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
Conklin CM; Craddock KJ; Have C; Laskin J; Couture C; Ionescu DN
J Thorac Oncol; 2013 Jan; 8(1):45-51. PubMed ID: 23196275
[TBL] [Abstract][Full Text] [Related]
22. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
[TBL] [Abstract][Full Text] [Related]
23. A subset of so-called dermal non-neural granular cell tumours are underlined by ALK fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma.
Perret RE; Jullie ML; Vergier B; Coindre JM; Le Loarer F
Histopathology; 2018 Sep; 73(3):532-534. PubMed ID: 29742298
[No Abstract] [Full Text] [Related]
24. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
Demidova I; Barinov A; Savelov N; Gagarin I; Grinevitch V; Stroiakovaski D; Popov M; Laktionov K; Gutorov S; Smolin A; Olshanskaya Y; Obukhova T
Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
[TBL] [Abstract][Full Text] [Related]
25. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M
BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405
[TBL] [Abstract][Full Text] [Related]
26. Epithelioid Fibrous Histiocytoma with
Secco LP; Libbrecht L; Seijnhaeve E; Eggers S; Dekairelle AF; De Roo AK
Dermatopathology (Basel); 2023 Jan; 10(1):25-29. PubMed ID: 36648781
[TBL] [Abstract][Full Text] [Related]
27. Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma.
Fritchie KJ; Dermawan JK; Astbury C; Sharma A; Bakhshwin A; Fuller L; Agrawal S; Wieland CN; Greipp PT; Azzato EM; Folpe AL; Billings SD
Virchows Arch; 2023 Aug; 483(2):237-243. PubMed ID: 37468653
[TBL] [Abstract][Full Text] [Related]
28. A comparative analysis of immunohistochemistry and fluorescent
Wagle PB; Jambhekar NA; Kumar R; Prabhash K; Pramesh CS; Desai SB; Noronha V; Karimundackal G; Shah A; Joshi A; Laskar SG; Jiwnani S; Pai T; Agarwal JP
Indian J Cancer; 2017; 54(1):148-154. PubMed ID: 29199679
[TBL] [Abstract][Full Text] [Related]
29. ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Marchetti A; Di Lorito A; Pace MV; Iezzi M; Felicioni L; D'Antuono T; Filice G; Guetti L; Mucilli F; Buttitta F
J Thorac Oncol; 2016 Apr; 11(4):487-95. PubMed ID: 26916631
[TBL] [Abstract][Full Text] [Related]
30. Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
Paolini D; Tiseo M; Demma F; Furneri G; Dionisi M; Akkermans M; Marchetti A
Clin Lung Cancer; 2018 Sep; 19(5):e735-e743. PubMed ID: 29937385
[TBL] [Abstract][Full Text] [Related]
31. Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.
Nakayama R; Togashi Y; Baba S; Kaku Y; Teramoto Y; Sakurai T; Haga H; Takeuchi K
Diagn Pathol; 2018 May; 13(1):28. PubMed ID: 29747676
[TBL] [Abstract][Full Text] [Related]
32. "Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant.
Martinez AP; Zou Y; Billings SD; Folpe AL
J Cutan Pathol; 2018 Feb; 45(2):99-103. PubMed ID: 29068085
[TBL] [Abstract][Full Text] [Related]
33. [Consistency of ALK Ventana-D5F3 immunohistochemistry interpretation in lung adenocarcinoma among Chinese histopathologists].
Li L; Zhang LP; Han YC; Wang WY; Jin Y; Xia QX; Liu YP; Xiang J; Liu C; Lu SS; Wu W; Chen Z; Pang J; Xi YF; Zheng YS; Gu DM; Fan J; Chang XN; Wang WW; Wang L; Zhang ZH; Yan XC; Sun Y; Li J; Hou F; Zhang JY; Huang RF; Lu JP; Wang Z; Hu YB; Yuan HT; Dong YJ; Wang L; Ke ZY; Geng JS; Guo L; Zhang J; Ying JM;
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):921-927. PubMed ID: 31818064
[No Abstract] [Full Text] [Related]
34. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
Hutarew G; Hauser-Kronberger C; Strasser F; Llenos IC; Dietze O
Histopathology; 2014 Sep; 65(3):398-407. PubMed ID: 24612196
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study of ALK rearrangement and clinicopathological implications in completely resected non- small cell lung cancer patients in Northern Thailand: role of screening with D5F3 antibodies.
Tantraworasin A; Lertprasertsuke N; Kongkarnka S; Euathrongchit J; Wannasopha Y; Saeteng S
Asian Pac J Cancer Prev; 2014; 15(7):3057-63. PubMed ID: 24815447
[TBL] [Abstract][Full Text] [Related]
36. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
37. Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study.
Wang Q; Zhao L; Yang X; Wei S; Zeng Y; Mao C; Lin L; Fu P; Lyu L; Li Z; Xiao H
Lung Cancer; 2016 May; 95():39-43. PubMed ID: 27040850
[TBL] [Abstract][Full Text] [Related]
38. [A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].
Wang Z; Wu X; Shi Y; Han X; Cheng G; Li L; Mu X; Zhang Y; Cui D; Zhang L; Fan Z; Zhu G; Ma L; Yang L; Di J; Liu D
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):742-8. PubMed ID: 26813592
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody.
Jain D; Jangra K; Malik PS; Arulselvi S; Madan K; Mathur S; Sharma MC
Indian J Cancer; 2017; 54(1):209-213. PubMed ID: 29199692
[TBL] [Abstract][Full Text] [Related]
40. An Unusual Case of an ALK-Negative Epithelioid Fibrous Histiocytoma in the External Auditory Canal.
Leff M; Quimby A; Morgan E; Brant JA
Laryngoscope; 2024 Jan; ():. PubMed ID: 38264975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
